A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense
Clinical trial NCT02849249 · COMPLETED
Trial details
- NCT number
- NCT02849249
- Sponsor
- Roxall Medicina España S.A
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.